Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Hellebrigenin

SKU: orb1684551

Description

Hellebrigenin is a small molecule that inhibits MAPK pathways (ERK, p38, JNK) and XIAP, downregulating Akt and inducing apoptosis via caspase activation and DNA damage. It demonstrates anti-proliferative effects in research models of oral squamous cell carcinoma and liver cancer, both in vitro and in vivo.

Research Area

Cell Biology, Epigenetics & Chromatin, Molecular Biology, Protein Biochemistry, Signal Transduction

Images & Validation

Key Properties

CAS Number465-90-7
MW416.51
Purity99.98% (May vary between batches)
FormulaC24H32O6
SMILESC(=O)[C@@]12[C@@]3([C@]([C@]4(O)[C@](C)(CC3)[C@H](CC4)C=5C=CC(=O)OC5)(CC[C@]1(O)C[C@@H](O)CC2)[H])[H]
TargetJNK,p38 MAPK,PARP,IAP,ERK,Apoptosis,Caspase

Bioactivity

In Vivo
Methods: Hellebrigenin (6 mg/kg, intraperitoneal injection, three times a week for 4 weeks) was used to treat oral cancer SCC-1 cell xenograft model mice to study its effects on tumor growth and mouse body weight. Methods: Hellebrigenin significantly inhibited tumor growth in the oral cancer SCC-1 cell xenograft model of mice without affecting mouse body weight.
In Vitro
Methods: Oral cancer SCC-1/47 cells and liver cancer HepG2 cells were treated with Hellebrigenin (2-8 nM, 24-72 h), and cell viability was detected by MTT assay. Results: Hellebrigenin inhibited the cell viability of oral cancer SCC-1/47 cells and liver cancer HepG2 cells in a dose- and time-dependent manner. Methods: Oral cancer SCC-1/47 cells were treated with Hellebrigenin (2-8 nM, 24 h), and the expression of related apoptosis proteins was detected by WB. Results: Hellebrigenin induced apoptosis in oral cancer SCC-1/47 cells and activated Caspase-3/8/9 and PARP cleavage, accompanied by upregulation of Bax/Bak and downregulation of Bcl-2/Bcl-xL, Cyclin A2/B1, and CDK4/6.

Storage & Handling

Storagekeep away from moisture,keep away from direct sunlight,The compound is unstable in solution. Please use soon | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

CDK, Akt, PARP, Hellebrigenin

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Hellebrigenin (orb1684551)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 150.00
5 mg
$ 310.00
10 mg
$ 440.00
25 mg
$ 690.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry